CA-VOGMASK
Air quality is the biggest threat to public health today. One important tool for breathing clean air is a filtering face mask. First in market to bring fashion to high efficiency, Vogmask has been awarded CE Mark Certificates on expanded range of Organic General Use Respirators to address the environmental challenges of poor air quality.
Notified Body BSI has awarded CE Mark Certificates for the Vogmask®
Organic product line certifying compliance with international regulatory
standards including:
Personal Protective Equipment (PPE) Directive
89/686/EEC and
General Product Safety Directive 2001/95 EC.
Vogmask Organics complements its premier CE Certified high fashion microfiber products. Organic cotton face-blanks provide cooler mask wearing in warm temperatures, natural material, and dual exhale valves in Certified Reusable masks.
Now offered in forty-one countries, worldwide, Vogmask is recognized as the premier face mask for fit, comfort, filtering efficiency, ecology, and style.
Vogmask® is a Registered Trademark of Ohlone Press, LLC.
Ohlone Press, LLC, received assistance from MPR Associates, Inc. in preparing technical and Quality Assurance content of the CE Mark application. MPR provides design, engineering, and regulatory compliance services for medical and consumer health care companies.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170301006341/en/
Contact:
Ohlone Press, LLC
Wendover Brown, 650-678-8652
Wendover@vogmask.com
www.vogmask.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KINAXIS-INC.26.4.2024 18:04:28 CEST | Press release
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions
VERTEX-PHARMA26.4.2024 17:44:28 CEST | Press release
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
SUZANO-S.A.26.4.2024 17:23:27 CEST | Press release
Suzano 2023 annual report on Form 20-F
MA-TAKEDA-PHARMACEUTICAL26.4.2024 14:31:34 CEST | Press release
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
WOLTERS-KLUWER26.4.2024 14:01:34 CEST | Press release
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom